Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder

Zhejiang University

Status: Unknown

Conditions: Phobia

Treatments: Drug: Sertraline; Device: vert

Study type: Interventional

Funder types: Other

Identifiers

NCT04977544

2019232

Details and patient eligibility

About

To explore the efficacy of drugs combined with virtual reality exposure therapy in the treatment of phobias compared with single drug treatment.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Meet the diagnostic criteria for phobias in DSM-IV.
• Age from 18 to 45 years old.
• Graduated from junior high school or above.
• No serious physical disease, no serious visual impairment, and no family history of mental illness.

Exclusion criteria

• Exclude other psychiatric diagnosis and treatment history.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

drug only

Active Comparator group

Description:

Sertraline was given as a single drug, with an initial dose of 50 mg/d, and gradually increased to the maximum dose of 200 mg/d after 2 weeks. The treating physician will determine the specific dose adjustment according to the patient's condition.

Treatment:

Drug: Sertraline

vert combine with drug

Experimental group

Description:

On the basis of sertraline drug treatment, phobia patients were given 2d/times from the 5th week, each 35-45min VR exposure treatment, 15 times as a course of treatment.

Treatment:

Device: vert

Drug: Sertraline